1st Quarter - Report
BROWNSTEIN HYATT FARBER SCHRECK, LLP for ROMARK GLOBAL PHARMA, LLC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Client
Income
$110,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 18, 2023 | $110,000 | Replaced |
| 1st Quarter - Amendment | Jul 19, 2023 | $60,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues regarding Biomedical Advanced Research and Development Authority Covid-19 Therapeutics'
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA JOHNSON BOLLIER | — |
| EMILY FELDER | — |
| SOHIL KHURANA | — |
| EDWARD RANDALL ROYCE | — |
| ADAM STEINMETZ | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.